restore LexA-VP16 destruction in Met30-null cells (Fig. 3A) , the fusion did rescue transcriptional activation, restoring wild-type levels of VP16 TAD activity (Fig. 3B , compare VP16 and Ub-VP16 in the Met30-null cells). Moreover, both Ub and the VP16 TAD are required for transcriptional activation in the Met30-null cells because Ub alone fused to LexA (Ub-⌬) did not activate transcription (14) . The observation that Met30's role in transcription can be complemented by fusion of LexA-VP16 to Ub argues that Met30 coactivates the VP16 TAD by signaling LexA-VP16 ubiquitylation. Moreover, the metabolic stability of the Ub-VP16 protein (Fig. 3A) demonstrates that it is Met30-mediated ubiquitylation, not destruction, that is required for transcriptional activation.
The requirement of ubiquitylation for VP16 activator function reveals that the degron function of the VP16 TAD is intimately tied to its ability to activate transcription. The link between these processes provides a simple explanation for the frequent and intimate overlap of TADs and degrons (3) (4) (5) . This requirement for ubiquitylation, which has not been observed in vitro, reveals a function for Ub distinct from its role in proteolysis (2) . Recent evidence has demonstrated that the 19S subunit of the proteasome plays an essential role in transcriptional elongation (15) . Given the role of the 19S complex as a Ub binding module (16) , it is possible that activator ubiquitylation serves to recruit the 19S complex to promoters, where the chaperone functions of this complex promote transcription elongation.
Although our data demonstrate that proteolysis is not required for transcriptional activation, it is important to note that Met30 does direct LexA-VP16 destruction. This suggests that activator destruction by the proteasome is a natural consequence of ubiquitylation. Because of the dual role of Ub in transcriptional activation and activator destruction, therefore, we propose that Ub "licenses" transcription factors by linking their activity to their destruction. We imagine that non-ubiquitylated activators are stable and inactive. Interactions of an activator with a Ubligase result in activator ubiquitylation, which simultaneously activates the transcription factor and primes it for destruction by the proteasome. Given the large number of transcription factors that are targeted for Ub-mediated proteolysis, it is possible that many transcription factors are regulated through this mechanism. Warner C. Greene 1,2,3 *
The nuclear expression and action of the nuclear factor kappa B (NF-B) transcription factor requires signal-coupled phosphorylation and degradation of the IB inhibitors, which normally bind and sequester this pleiotropically active factor in the cytoplasm. The subsequent molecular events that regulate the termination of nuclear NF-B action remain poorly defined, although the activation of de novo IB␣ gene expression by NF-B likely plays a key role. Our studies now demonstrate that the RelA subunit of NF-B is subject to inducible acetylation and that acetylated forms of RelA interact weakly, if at all, with IB␣. Acetylated RelA is subsequently deacetylated through a specific interaction with histone deacetylase 3 (HDAC3). This deacetylation reaction promotes effective binding to IB␣ and leads in turn to IB␣-dependent nuclear export of the complex through a chromosomal region maintenance-1 (CRM-1)-dependent pathway. Deacetylation of RelA by HDAC3 thus acts as an intranuclear molecular switch that both controls the duration of the NF-B transcriptional response and contributes to the replenishment of the depleted cytoplasmic pool of latent NF-B-IB␣ complexes.
NF-B corresponds to an inducible transcription factor complex that plays a pivotal role in regulating the inflammatory, immune, and anti-apoptotic responses in mammals (1, 2) . The prototypical NF-〉 complex, which corresponds to a heterodimer of p50 and RelA subunits, is sequestered in the cytoplasm by its assembly with a family of inhibitory proteins termed the IBs (1). Stimulus-induced phosphorylation of two NH 2 -terminal serines in the IBs, mediated by a macromolecular IB kinase complex (IKK) (3), triggers the rapid ubiquitination and subsequent degradation of this inhibitor by the 26S proteasome complex. The liberated NF-〉 heterodimer rapidly translocates into the nucleus, where it engages cognate 〉 enhancer elements and alters gene expression. The NF-B complex also recruits the p300/CBP and P/CAF coactivators, which participate in the activation of target gene transcription (4-6). Phosphorylation of an NH 2 -terminal site in RelA by protein kinase A facilitates NF-B assembly with CBP/p300 (7). Both CBP and p300
contain histone acetyltransferase activity that has been implicated in the regulation of gene expression. These effects involve acetylation of core histones leading to changes in chromatin structure (8-13) as well as direct acetylation of select host transcription factors like p53, GATA-1, and E2F, which alters their biological function (9, 10) .
Although much progress has been made in understanding the biochemical events that underlie NF-B induction, much less is known about how activated nuclear forms of NF-B are negatively regulated, ensuring a transient transcriptional response. Prior studies have demonstrated that the IB␣ gene is induced by NF-B (14-16) and that the de novo expression of IB␣ proteins, which display nucleocytoplasmic shuttling properties, participates in a negative feedback system limiting the NF-B transcriptional response (17, 18) . We now demonstrate that nuclear RelA is subject to reversible acetylation and that this posttranslational modification plays a pivotal role in NF-B regulation by governing IB␣ binding to RelA and the nuclear export of the NF-B complex.
We first observed that trichostatin A (TSA), a specific inhibitor of the multiple histone deacetylases (HDACs) (11), enhanced tumor necrosis factor (TNF)-␣-induced, but not basal, expression of a Bluciferase reporter gene (Fig. 1A) . In addition, TSA enhanced nuclear NF-B DNA binding after TNF-␣ stimulation but did not itself stimulate NF-B binding (Fig. 1B) . TSA also did not alter the binding of the constitutively expressed Sp1 transcription factor in either the presence or absence of TNF-␣ (Fig. 1B, lower panel) . Immunoblotting of the nuclear extracts with antibodies to RelA (anti-RelA) revealed sustained nuclear RelA expression in the presence of TSA (Fig.  1C) . Together, these results indicate that TSA enhances TNF-␣-induced NF-B DNA binding, likely by prolonging intranuclear expression of RelA.
TSA broadly inhibits the action of the HDACs. HDACs function not only to deacetylate core histones leading to repressive changes in chromatin structure but also to deacetylate various host transcription factors, altering their transcriptional activity (10-13). We assessed potential inhibitory effects of various HDACs on NF-B action by cotransfecting 293T cells with expression vectors encoding HDAC1, 2, 3, 4, 5, or 6 and a B-luciferase reporter followed by stimulation with TNF-␣ for 5 hours (Fig.  1D) . Although each of the HDACs was comparably expressed, only HDAC3 inhibited TNF-␣-induced B-luciferase activity (lanes 7 and 8). This inhibitory effect of HDAC3 was abrogated in the presence of TSA, indicating that the deacetylase function of HDAC3 was required for these biological effects (Web fig.  1 ) (19) . Consistent with this action of HDAC3, we found that the RelA subunit of NF-B is acetylated in vivo (Fig. 2A, lane 2 (Fig. 2B) . Together, these studies reveal that NF-B is subject to reversible acetylation and that HDAC3 plays a central role in its deacetylation.
The potential participation of the p300, 1 to 4) or HDAC3-expression vector DNA and cultured for 24 hours, followed by stimulation with TNF-␣ (10 ng/ml) for 0, 10, 30, or 90 min. Nuclear extracts were prepared and EMSAs performed as described in Fig. 1B ( panels 1 and 2) . TNF-␣-induced degradation of I〉␣ was analyzed in the cytoplasmic extracts of these cultures by immunoblotting with anti-IB␣ (C-21, Santa Cruz) ( panel 3). Levels of nuclear RelA were assessed by immunoblotting nuclear extracts with specific anti-RelA CBP, and P/CAF acetyltransferases in the acetylation of RelA was next investigated. When 293T cells were cotransfected with RelA, IB␣, and p300, and stimulated with TNF-␣, inducible acetylation of RelA was detected (Fig. 2C) . Coexpression of either p300 or CBP, but not P/CAF, with RelA produced a dose-dependent acetylation of T7-RelA [Web fig. 2 (19) ]. Together, these findings demonstrate that endogenous RelA is acetylated in a signal-coupled manner likely mediated by p300 and CBP.
Coimmunoprecipitation of T7-RelA and HDAC3 in COS-7 cells suggests a physical interaction between these two proteins in vivo (Fig. 3A) . In contrast, no interaction between RelA and HDAC1 was detected despite comparable levels of both HDACs being expressed (Fig. 3A) . Moreover, anti-HDAC3 effectively coimmunoprecipitated endogenous RelA from HeLa cells, whereas only trace amounts of RelA immunoprecipitated with anti-HDAC1 (Fig. 3B) . By using coimmunoprecipitation assays and the mammalian two-hybrid system (20), we found that NH 2 -terminal regions of both HDAC3 and RelA are required for the assembly of these two proteins in vivo [Web fig. 3 ) (19)].
Studies were next performed to define the molecular basis for HDAC3-mediated inhibition of TNF-␣ activation of NF-B. Expression of HDAC3 in HeLa cells (ϳ50% transfection efficiency) diminished both NF-B DNA-binding activity (Fig. 3C, panel 1) and levels of nuclear RelA ( panel 4). In contrast, HDAC3 expression did not alter TNF-␣-induced degradation of IB␣ occurring in the cytoplasm ( panel 3), nor did it markedly change the levels of Sp1 DNA-binding activity ( panel 2). Together with the results presented in Fig. 1C , these findings raise the possibility that HDAC3 may regulate the intracellular trafficking of RelA. A precedent for acetylation influencing the intracellular trafficking of a transcription factor is provided by recent studies on hepatocyte nuclear factor-4 and class II transactivator (CIITA) (21, 22) . To monitor potential effects of HDAC3 on the intracellular trafficking of RelA, we expressed green fluorescent proteinRelA fusion proteins (GFP-RelA) in HeLa cells in the presence and absence of HDAC3 (Fig.  3D) . When expressed alone or with HDAC1, GFP-RelA localized to the nucleus, whereas the coexpression of HDAC3 resulted in a predominantly cytoplasmic pattern of GFP-RelA expression. This cytoplasmic relocalization of GFP-RelA induced by HDAC3 did not occur in the presence of TSA. These effects of HDAC3 appeared to result from nuclear export of GFPRelA because the addition of leptomycin B, a known inhibitor of CRM-1/exportin-1-dependent nuclear export (23) , preserved the nuclear pattern of GFP-RelA epifluorescence. These findings suggest that HDAC3-mediated deacetylation of RelA promotes its export from the nucleus to the cytoplasm.
Among the target genes activated by NF-B is the IB␣ gene (14-16). The resultant de novo synthesis of IB␣ serves to replenish the intracellular stores of this inhibitor depleted during the course of NF-B activation. IB␣ also displays nucleocytoplasmic shuttling properties and likely retrieves nuclear NF-B complexes, thereby contributing to the termination of the NF-B transcriptional response (17, 18) . We next examined whether the acetylation status of RelA regulates its assembly with IB␣. The acetylation of RelA induced by the coexpression of increasing amounts of p300 was associated with markedly diminished binding of RelA to GST-IB␣ matrices (Fig. 4A, lanes  3 and 4) . However, the coexpression of increasing amounts of HDAC3 in the presence of p300 restored RelA binding to GST-IB␣ (Fig. 4A,  lanes 5 and 6) . Immunoblotting of the T7-RelA proteins with antibodies to acetylated lysine confirmed dose-related increases in RelA acetylation by p300 in lanes 3 and 4 and doserelated deacetylation of RelA by HDAC3 in lanes 5 and 6 (24) . These findings suggest that acetylation of RelA prevents IB␣ binding, whereas deacetylation of RelA by HDAC3 stimulates IB␣ binding.
To test whether the HDAC3-induced nuclear export of RelA is dependent on IB␣, we studied the subcellular localization of GFP-RelA in murine embryo fibroblasts (MEFs) isolated from wild-type or IB␣ -/-mice produced by targeted gene disruption (25) (Fig. 4B) . In wild-type MEFs, GFPRelA was principally expressed in the nucleus ( panel a), whereas the coexpression of HDAC3 induced a cytoplasmic pattern of GFP-RelA epifluorescence ( panel b). However, a very different pattern was obtained in the IB␣ -/-MEFs. Whereas GFP-RelA also exhibited a nuclear pattern of epifluorescence, the coexpression of HDAC3 in these IB␣ -/-MEFs failed to induce a cytoplasmic redistribution of RelA ( panel d). Reconstitution of these IB␣ -/-cells by transfection with small quantities of an IB␣ expression vector restored HDAC3-induced cytoplasmic expression of the GFP-RelA protein ( panel f ). In the absence of HDAC3, GFP-RelA remained principally nuclear, indicating that the levels of IB␣ expressed were not sufficient on their own to produce cytoplasmic sequestration of GFP-RelA in these IB␣ -/-MEFs ( panel e). These results indicate that IB␣ is required for the nuclear export of deacetylated forms of RelA, which display increased binding of IB␣.
These findings reveal a new mechanism through which nuclear NF-B function is regulated (Fig. 4C) . RelA is subject to stimuluscoupled acetylation likely mediated through the p300 and CBP coactivators. One biological consequence of this modification is that acetylated RelA becomes a very poor substrate for binding by newly synthesized IB␣. Whether p50 or perhaps IB␣ are similarly subject to biologically important acetylation/deacetylation reactions remains to be explored. Our studies identify acetylated RelA as a novel nonhistone substrate of HDAC3. As such, HDAC3-mediated deacetylation functions as an intranuclear molecular switch that when activated initiates a series of events culminating in the termination of the NF-B transcriptional response. The IB␣-dependent nuclear export of the HDAC3-deacetylated RelA-containing complexes also serves to replenish the depleted cytoplasmic pool of latent NF-B-IB␣ complexes needed for the next inductive NF-B response in these cells.
Allosteric Activation of a Spring-Loaded Natriuretic Peptide Receptor Dimer by Hormone Xiao-lin He, Dar-chone Chow, Monika M. Martick, K. Christopher Garcia* Natriuretic peptides (NPs) are vasoactive cyclic-peptide hormones important in blood pressure regulation through interaction with natriuretic cell-surface receptors. We report the hormone-binding thermodynamics and crystal structures at 2.9 and 2.0 angstroms, respectively, of the extracellular domain of the unliganded human NP receptor (NPR-C) and its complex with CNP, a 22-amino acid NP. A single CNP molecule is bound in the interface of an NPR-C dimer, resulting in asymmetric interactions between the hormone and the symmetrically related receptors. Hormone binding induces a 20 angstrom closure between the membrane-proximal domains of the dimer. In each monomer, the opening of an interdomain cleft, which is tethered together by a linker peptide acting as a molecular spring, is likely a conserved allosteric trigger for intracellular signaling by the natriuretic receptor family.
The natriuretic peptides (NPs) are three homologous peptide hormones that play important roles in the maintenance of cardiovascular homeostasis, blood pressure, and body fluid regulation (i.e., natriuresis) (1). Collectively, these hormones function as an endogenous counterbalance to the renin-angiotensin/aldosterone system, as well as the hypothalamic/pituitary/adrenal axis. The three members of this family are atrial (ANP) and brain (BNP) natriuretic peptides, which are produced by the heart; and CNP, which is expressed in endothelial cells (1) . ANP and BNP are thought to be the primary regulators of peripheral natriuretic activity; CNP is present mainly in the brain. ANP, BNP, and CNP are highly homologous (ϳ70% identical) and share as a common motif a 17-amino acid loop formed by a disulfide bond (Fig. 1) . The lack of defined structure(s) in solution and the questionable relevance of "lowest energy" solution conformations to the receptor-bound conformation of peptide hormones mean that assessing the bioactive conformations of these peptides remains a general problem (2) . The actions of the NPs are mediated by three homologous single-transmembrane, glycosylated cell-surface receptors (NPR-A, -B, and -C) (3) (4) (5) . These receptors possess about 30% homologous extracellular ligandbinding domains (ECDs) (ϳ450 amino acids) with conserved topologies but possess different downstream activation mechanisms. NPR-C is the most promiscuous of the receptors, binding to all NPs with high affinity, whereas NPR-A and NPR-B are more specific for ANP and CNP, respectively (6) . In the cases of NPR-A and NPR-B, hormone binding to the ECDs results in the production of intracellular cyclic guanosine 3Ј,5Ј-monophosphate by a guanylyl-cyclase activity that resides in the intracellular domains (5, 7) . For NPR-C, which represents over 95% of NPR in vivo, ligand binding results in both internalization and degradation (i.e., clearance), as well as signaling by heterotrimeric GTP-
